Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
"Gadolinium-Phobia:" Not a Helpful "Criterion" for Indication for Gadolinium-based Contrast Agent Administration in Multiple Sclerosis.
Rethinking the importance of paroxysmal and unusual symptoms as first clinical manifestation of multiple sclerosis: They do matter.
Poster 373-A Immunoglobulin Treatment of Miller Fisher Variant of Acute Demyelinating Inflammatory Polyneuropathy with Underlying Chronic Inflammatory Demyelinating Polyneuropathy: A Case Report.
Gender effect on neuromyelitis optica spectrum disorder with aquaporin4-immunoglobulin G.
Linc-MAF-4 regulates Th1/Th2 differentiation and is associated with the pathogenesis of multiple sclerosis by targeting MAF.
Bedside to bench to bedside research: Estrogen receptor beta ligand as a candidate neuroprotective treatment for multiple sclerosis.
Hemiplegic Migraine Presenting with Prolonged Somnolence: A Case Report.
Differential Expression of Glucocorticoid Receptor Noncoding RNA Repressor Gas5 in Autoimmune and Inflammatory Diseases.
Improved Automatic Detection of New T2 Lesions in Multiple Sclerosis Using Deformation Fields.
When to Suspect and How to Diagnose Mitochondrial Disorders?
Rescue effects of intravenous immunoglobulin on optic nerve degeneration in a rat model of neuromyelitis optica.
B cells and antibodies in progressive multiple sclerosis: Contribution to neurodegeneration and progression.
Adipose-Derived Stem Cells Enhance Axonal Regeneration through Cross-Facial Nerve Grafting in a Rat Model of Facial Paralysis.
Immunological considerations for treating globoid cell leukodystrophy.
To fingolimod and beyond: The rich pipeline of drug candidates that target S1P signaling.
Estrogen receptors and esterol-dependent neuroprotective actions: a pilot study.
Autoimmunity meets genetics: Multiple sclerosis in a patient with Kallmann syndrome.
An attenuated immune response by Schwann cells and macrophages inhibits nerve regeneration in aged rats.
Acute flaccid weakness with myelopathy and peripheral nerve involvement in 2 children: Recent characterization of a previously observed phenomenon.
Therapeutic developments for autoimmune demyelinating diseases: Musing from an MD (mouse doctor).
Cognitive impairment among patients with multiple sclerosis: associations with employment and quality of life.
Growing Older With a Physical Disability: A Special Application of the Successful Aging Paradigm.
"A new imaging modality to non-invasively assess multiple sclerosis pathology".
The Relationship Between Brain MR Spectroscopy and Disability in Multiple Sclerosis: 20-Year Data from the U.S. Glatiramer Acetate Extension Study.
A pilot study of changes in functional brain activity during a working memory task after mSMT treatment: The MEMREHAB trial.
Pages
« first
‹ previous
…
850
851
852
853
854
855
856
857
858
…
next ›
last »